FDA Inspection
BHS IncBHS Inc – FDA Inspection, Dec 4, 2012
Record Details
This FDA Inspection record concerns BHS Inc, with an inspection on December 4, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- BHS Inc
- Inspection Date
- December 4, 2012
- Product Type
- Drugs
View Company Profile
ID · f6cd8479-2087-4ba5-bb40-e86b3794428d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 810190
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.101(c)Weighing/measuring/subdividing supervision
- 21 CFR 211.125(c)Label reconciliation discrepancies evaluation/investigation
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.130(c)Lot or control number assigned
- 21 CFR 211.160(a)Lab controls established, including changes
- 21 CFR 211.22(a)Authority lacking to review records, investigate errors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BHS Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 2, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BHS Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.